Skip to content

Study · Not a test of the peptide alone · 2025

1 result

Cerebrolysin treatment in a case of post-herpes simplex encephalitis with neuropsychiatric symptoms.

Lee YS, Seo J, Yim SH

Journal of medicine and life1 Sept 2025

PMID41178897 (opens in a new tab)PMCIDPMC12577782 (opens in a new tab)DOI10.25122/jml-2025-0052 (opens in a new tab)PepBankPUB-41178897
Download PDFPubMedAsk about this study
Jump to 1 result

Summary

Herpes simplex encephalitis (HSE) is a severe central nervous system (CNS) infection associated with cognitive decline, psychotic symptoms, and epilepsy. Despite aggressive antiviral and corticosteroid treatments, post-HSE complications remain challenging to manage. We report a case of a 33-year-old female patient with post-HSE neuropsychiatric symptoms who showed significant improvement following Cerebrolysin treatment. The patient was treated with acyclovir and dexamethasone in the acute phase, followed by Cerebrolysin administration in the post-acute phase. This case highlights the potential therapeutic role of Cerebrolysin in managing post-encephalitic cognitive dysfunction, underscoring the need for further studies.
CC BYText from Europe PMC. Highlighted sentences are the source of results.

Results from this study1

No result from this study comes from a test of the peptide.

Studies that did not test the peptide alone1

In this study, Cerebrolysin was a lab tool or a carrier, part of a mix, or the subject of a lab method. These results are not evidence about taking Cerebrolysin.

  1. 01HumanNot a test of Cerebrolysin aloneCase report or seriesEfficacy outcome

    In a woman with post-HSE neuropsychiatric symptoms, significant improvement followed acute acyclovir and dexamethasone, then post-acute Cerebrolysin.

    In plain wordsIn a woman with symptoms after herpes encephalitis, improvement followed acyclovir and dexamethasone, then Cerebrolysin.

    Peptide
    Cerebrolysin
    Outcome
    DecreasePost-HSE neuropsychiatric symptoms
    Study

    n = 1

    Outcome group
    Neuroprotection · Nervous system and cognition

    Source sentences

    Summary
    We report a case of a 33-year-old female patient with post-HSE neuropsychiatric symptoms who showed significant improvement following Cerebrolysin treatment.
    1 context sentence
    Summary · context
    The patient was treated with acyclovir and dexamethasone in the acute phase, followed by Cerebrolysin administration in the post-acute phase.

    In this study, Cerebrolysin was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking Cerebrolysin.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    14 Oct 2026, 05:02 UTC

    Study results updated

  2. Version 1

    14 Oct 2026, 01:46 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.